Titel

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 

Kurzzusammenfassung

This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of tocilizumab (TCZ) compared with a matching placebo in combination with standard of care (SOC) in hospitalized patients with severe COVID-19 pneumonia.

Zentren/Kontakt:

Universitatsklinikum Düsseldorf

Medizinische Hochschule Hannover

Universitatsklinikum Kiel

Uniklinik Köln

LMU Klinikum der Universität München

Details

 

Stand: 05.05.2020, Quelle: www.clinicaltrials.gov

Menü